Search Results 7371-7380 of 41179 for oral

1. A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With HIV-1 - Mayo Clinic

   Prior receipt of immunomodulatory or immunosuppressive (including intravenous infusion or oral steroids at any dose, but excluding steroids that are inhaled, ...

2. Christopher Serago, Ph.D. - Doctors and Medical Staff - Mayo Clinic

   2015 - present. Oral Board ExaminerAmerican Board of Radiology. 2014 - present. MemberRadiation Oncology IT Governance, Radiation Oncology Specialty Council ...

3. Osarenoma U. Olomu, M.D. - Doctors and Medical Staff - Mayo Clinic

   2003. Outstanding Oral Presentation awardNational Cancer Institute, National Institutes of Health, National Institutes of Health. 2001. Dean's Honor List ...

4. Prostatitis - Diagnosis and treatment - Mayo Clinic

   Sometimes, a healthcare professional gently massages the prostate during a rectal exam. This is to release prostate fluid into the urethra. A urine sample ...

5. Vaginal dryness Causes - Mayo Clinic

   Lower estrogen levels are the main cause of vaginal dryness. Estrogen is a hormone that helps keep vaginal tissue healthy and moist. Other causes of vaginal ...

6. Study to Assess the Effectiveness and Safety of Bradanicline in Patients with Chronic Cough - Mayo Clinic

   Acceptable birth control methods include established use of oral, injected, or implanted hormonal methods of contraception; intrauterine device (IUD) or ...

7. A Study Of Simvastatin Therapy For Moderate And Severe COPD - Mayo Clinic

   ... oral or barrier contraceptive) for the duration of the study; Using estradiol compounds for contraception. Postmenopausal estradiol compounds for hormone ...

8. A Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 with Terlipressin Treatment - Mayo Clinic

   Use of short-term (< 2 weeks) oral neomycin for acute encephalopathy is acceptable. Current or recent (within 4 weeks) renal replacement therapy; Superimposed ...

9. A Study to Evaluate the Pharmacokinetics of Low-Dose Bevacuzimab in Reducing Free Plasma VEGF-A in Hemodialysis Patients - Mayo Clinic

   ... oral contraceptives in combination with a barrier method, some intrauterine contraceptive devices, sexual abstinence, or a vasectomized partner; Malignancy ...

10. Study Of Lunresertib Alone Or In Combination With RP-3500 Or Debio 0123 In Patients With Advanced Solid Tumors - Mayo Clinic

    Ability to swallow and retain oral medications. Acceptable hematologic and organ function at screening. Negative pregnancy test (serum) for women of ...